Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

NCT00417716 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Diabetes Mellitus Type 2
Diabetic Macular Edema

Interventions

DRUG: Intravitreal Bevacizumab

Sponsor

Asociación para Evitar la Ceguera en México